This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
public health | 1057 |
infectious diseases | 865 |
stem cells | 817 |
acute respiratory | 739 |
respiratory tract | 699 |
cell lines | 698 |
respiratory syndrome | 692 |
extracellular vesicles | 633 |
human rights | 613 |
gene expression | 609 |
virus infection | 586 |
present document | 571 |
epithelial cells | 564 |
summary conclusion | 561 |
food safety | 548 |
human metapneumovirus | 546 |
immune system | 533 |
human security | 525 |
mass spectrometry | 519 |
severe acute | 513 |
influenza virus | 501 |
united states | 501 |
human health | 486 |
amino acid | 485 |
stem cell | 484 |
immune response | 483 |
avian influenza | 463 |
cell line | 453 |
respiratory syncytial | 447 |
animal models | 438 |
endothelial cells | 436 |
syncytial virus | 427 |
infectious disease | 407 |
cell types | 405 |
human milk | 399 |
cell culture | 394 |
safety authority | 390 |
european food | 390 |
influenza viruses | 355 |
monoclonal antibodies | 350 |
amino acids | 331 |
immune responses | 326 |
nervous system | 319 |
mouse model | 316 |
syndrome coronavirus | 312 |
west nile | 307 |
hong kong | 305 |
human genome | 303 |
may also | 298 |
human disease | 295 |
cancer cells | 294 |
escherichia coli | 292 |
human coronavirus | 291 |
doc id | 288 |
cord uid | 288 |
novel coronavirus | 286 |
breast cancer | 283 |
human bocavirus | 274 |
hemorrhagic fever | 271 |
lower respiratory | 269 |
growth factor | 266 |
middle east | 264 |
electron microscopy | 263 |
human transmission | 260 |
risk factors | 260 |
node length | 256 |
length cov | 256 |
virsorter node | 256 |
flow cytometry | 256 |
monoclonal antibody | 255 |
western blot | 255 |
emerging infectious | 247 |
smooth muscle | 246 |
important role | 245 |
cat virsorter | 241 |
cell death | 237 |
phage display | 236 |
pluripotent stem | 236 |
cell cultures | 234 |
human population | 233 |
ebola virus | 231 |
health care | 228 |
respiratory viruses | 227 |
antibiotic resistance | 226 |
hiv aids | 226 |
bone marrow | 224 |
risk assessment | 224 |
mg kg | 224 |
type i | 222 |
one health | 221 |
innate immune | 220 |
nipah virus | 220 |
nile virus | 218 |
clinical trials | 218 |
oxidative stress | 216 |
human beings | 214 |
cell surface | 212 |
present study | 212 |
dengue virus | 212 |
blood pressure | 208 |
mrna expression | 206 |
closely related | 206 |
animal model | 205 |
east respiratory | 204 |
viral infections | 204 |
immunodeficiency virus | 203 |
central nervous | 203 |
climate change | 201 |
protein expression | 200 |
ng ml | 200 |
developing countries | 199 |
fever virus | 198 |
dendritic cells | 195 |
conclusions reached | 195 |
authority reserves | 194 |
human proteins | 194 |
issues addressed | 194 |
awarded following | 193 |
tender procedure | 193 |
output adopted | 193 |
transparency principle | 193 |
published complying | 193 |
rna viruses | 192 |
world health | 191 |
transcription factor | 188 |
without prejudice | 186 |
leydig cells | 185 |
breast milk | 185 |
human populations | 185 |
bodies identified | 184 |
viral replication | 184 |
human respiratory | 181 |
zoonotic diseases | 180 |
host cell | 179 |
human cells | 178 |
sertoli cells | 178 |
cell proliferation | 178 |
tract infections | 177 |
immune cells | 176 |
young children | 174 |
peripheral blood | 174 |
human sars | 173 |
human coronaviruses | 173 |
respiratory disease | 173 |
human immunodeficiency | 172 |
mouse models | 171 |
nitric oxide | 170 |
gut microbiota | 169 |
pregnant women | 169 |
sars coronavirus | 167 |
upper respiratory | 167 |
health organization | 165 |
highly pathogenic | 164 |
laser desorption | 164 |
valley fever | 163 |
virus type | 163 |
neu gc | 163 |
rift valley | 163 |
even though | 163 |
sialic acid | 162 |
binding protein | 161 |
plant mirnas | 160 |
human infection | 160 |
yellow fever | 158 |
transgenic mice | 158 |
seminiferous tubules | 158 |
viral infection | 157 |
host cells | 155 |
germ cell | 155 |
plasma membrane | 155 |
human lung | 153 |
additional file | 153 |
global health | 153 |
skeletal muscle | 152 |
tumor cells | 152 |
years ago | 150 |
first time | 149 |
results suggest | 146 |
derived evs | 146 |
dna damage | 145 |
epithelial cell | 145 |
cell type | 145 |
time pcr | 145 |
host range | 144 |
human rhinovirus | 144 |
disease emergence | 143 |
significantly higher | 143 |
human infections | 142 |
mesenchymal stem | 142 |
wide range | 142 |
virus infections | 140 |
neutralizing antibodies | 139 |
nanoparticle tracking | 139 |
respiratory infections | 139 |
desorption ionization | 139 |
two different | 138 |
common cold | 138 |
embryonic stem | 138 |
extracellular matrix | 137 |
protein kinase | 137 |
disease control | 136 |
sertoli cell | 136 |
endothelial cell | 135 |
nucleic acid | 135 |
viral rna | 135 |
cancer cell | 135 |
tracking analysis | 135 |
gene therapy | 135 |
receptor binding | 135 |
increased risk | 134 |
control measures | 134 |
animal health | 133 |
large number | 133 |
nucleic acids | 132 |
wild type | 132 |
cystic fibrosis | 131 |
united nations | 131 |
infected cells | 131 |
ex vivo | 130 |
cell cycle | 130 |
high levels | 130 |
leydig cell | 129 |
animal species | 129 |
gestational age | 129 |
human proteome | 129 |
human airway | 129 |
ms ms | 129 |
herpes simplex | 128 |
bat cov | 128 |
th century | 128 |
recent years | 128 |
prostate cancer | 128 |
tissue culture | 128 |
encephalitis virus | 127 |
significantly increased | 126 |
genome sequence | 126 |
wild animals | 126 |
molecular mechanisms | 126 |
transcription factors | 125 |
fi rst | 125 |
human influenza | 125 |
type ii | 124 |
innate immunity | 124 |
human pathogens | 124 |
growth factors | 124 |
assisted laser | 123 |
recent studies | 123 |
western blotting | 123 |
spike protein | 122 |
human body | 122 |
human cases | 122 |
human diseases | 122 |
chain reaction | 122 |
zoonotic disease | 121 |
clinical signs | 121 |
dependent manner | 121 |
human microbiome | 119 |
new york | 119 |
infectious agents | 118 |
data suggest | 118 |
polymerase chain | 118 |
zika virus | 118 |
direct contact | 118 |
severe disease | 118 |
side effects | 117 |
binding sites | 117 |
rhesus macaques | 117 |
significantly reduced | 117 |
sialic acids | 117 |
human monoclonal | 117 |
incubation period | 117 |
systematic review | 117 |
spinal cord | 116 |
genetic diversity | 116 |
small intestine | 116 |
different types | 116 |
antimicrobial resistance | 116 |
antimicrobial activity | 115 |
widely used | 115 |
capillary electrophoresis | 115 |
high affinity | 115 |
generation sequencing | 114 |
body weight | 114 |
heart failure | 114 |
muscle cells | 114 |
mrna levels | 113 |
better understanding | 113 |
binding site | 111 |
differentially expressed | 111 |
nonhuman primates | 111 |
genetically modified | 111 |
saudi arabia | 111 |
sars cov | 111 |
million people | 111 |
united kingdom | 111 |
inflammatory response | 110 |
tof ms | 110 |
performed using | 110 |
inflammatory cytokines | 109 |
hendra virus | 109 |
risk factor | 109 |
ovarian cancer | 109 |
antimicrobial peptides | 109 |
blot analysis | 109 |
may lead | 108 |
results indicate | 108 |
guinea pigs | 108 |
mammalian cells | 108 |
may play | 108 |
may contribute | 108 |
high risk | 108 |
human brain | 108 |
fruit bats | 107 |
reproductive tract | 107 |
antiviral activity | 107 |
exogenous ncrnas | 107 |
human immune | 106 |
host immune | 106 |
west africa | 106 |
human plasma | 106 |
previous studies | 105 |
lung tissue | 105 |
taken together | 105 |
rabies virus | 104 |
intrinsic disorder | 104 |
simplex virus | 104 |
fatty acids | 103 |
analysis revealed | 103 |
staphylococcus aureus | 103 |
control group | 102 |
mg ml | 102 |
mammary gland | 102 |
vaccine development | 102 |
coronavirus infection | 101 |
acid glycoprotein | 101 |
lentiviral vector | 101 |
rete testis | 101 |
also found | 101 |
blood samples | 100 |
stranded rna | 100 |
tract infection | 100 |
also known | 100 |
gastrointestinal tract | 100 |
commonly used | 100 |
first trimester | 100 |
determine whether | 99 |
north america | 99 |
machine learning | 99 |
multiple sclerosis | 99 |
hiv infection | 99 |
barr virus | 99 |
phylogenetic analysis | 99 |
natural selection | 98 |
may provide | 98 |
respiratory distress | 98 |
gene transfer | 98 |
germ cells | 98 |
infl uenza | 98 |
natural killer | 98 |
protein interaction | 98 |
host species | 98 |
virus replication | 97 |
signaling pathways | 97 |
protein interactions | 97 |
infect humans | 97 |
per year | 97 |
human serum | 97 |
adverse effects | 97 |
primary human | 97 |
type diabetes | 96 |
zoonotic viruses | 96 |
blood cells | 95 |
human host | 95 |
reactive oxygen | 95 |
cancer patients | 94 |
protein synthesis | 94 |
medical center | 94 |
knockout mice | 94 |
metapneumovirus infection | 94 |
expression levels | 94 |
coronavirus disease | 93 |
chronic diseases | 93 |
culture medium | 93 |
nk cells | 93 |
molecular biology | 93 |
informed consent | 93 |
sequence analysis | 93 |
dna methylation | 93 |
real time | 93 |
adaptive immune | 93 |
air pollution | 93 |
crispr cas | 93 |
commercially available | 92 |
next generation | 92 |
resistance genes | 92 |
least one | 92 |
animal welfare | 92 |
host defence | 92 |
mycobacterium tuberculosis | 92 |
lung cancer | 92 |
pandemic influenza | 92 |
derived exosomes | 92 |
molecular weight | 92 |
pg ml | 92 |
defi ciency | 91 |
saharan africa | 91 |
progenitor cells | 91 |
family members | 91 |
highly conserved | 91 |
necrosis factor | 90 |
clinical symptoms | 90 |
respiratory illness | 90 |
human embryonic | 90 |
species transmission | 90 |
drug resistance | 90 |
equine encephalitis | 90 |
case report | 90 |
may result | 90 |
significant increase | 89 |
like receptor | 89 |
causative agent | 89 |
key role | 89 |
novel human | 89 |
tract disease | 89 |
human pluripotent | 89 |
target cells | 89 |
human skin | 88 |
mass spectrometric | 88 |
small rna | 88 |
transmission electron | 88 |
specific antibodies | 88 |
gi tract | 88 |
clinical features | 87 |
dengue viruses | 87 |
model systems | 87 |
oral administration | 87 |
heart disease | 87 |
culture media | 87 |
cell adhesion | 87 |
drinking water | 87 |
disease transmission | 86 |
total rna | 86 |
findings suggest | 86 |
oxygen species | 86 |
significant differences | 86 |
colorectal cancer | 86 |
stromal cells | 86 |
give rise | 85 |
cell differentiation | 85 |
mortality rate | 85 |
fold higher | 85 |
protein levels | 85 |
umbilical cord | 85 |
weight loss | 85 |
new world | 84 |
international law | 84 |
lymph nodes | 84 |
signal transduction | 84 |
exclusion chromatography | 84 |
lung injury | 84 |
poorly understood | 84 |
respiratory virus | 84 |
lyme disease | 84 |
emerging viruses | 84 |
extracellular vesicle | 84 |
human gut | 83 |
converting enzyme | 83 |
influenza pandemic | 83 |
intensive care | 83 |
neu ac | 83 |
companion animals | 82 |
pathogenic avian | 82 |
biomedical research | 82 |
complete genome | 82 |
free radicals | 82 |
derived organoids | 82 |
viral load | 82 |
airway epithelial | 82 |
gut microbiome | 82 |
naturally occurring | 82 |
different species | 82 |
endoplasmic reticulum | 82 |
infected patients | 81 |
previously described | 81 |
outer membrane | 81 |
borne diseases | 81 |
recombinant human | 81 |
blood flow | 81 |
usa introduction | 81 |
normal human | 81 |
humanized mice | 81 |
genes involved | 81 |
autoimmune diseases | 81 |
clinical disease | 81 |
rna virus | 80 |
crystal structure | 80 |
new virus | 80 |
disease progression | 80 |
identifi ed | 79 |
wound healing | 79 |
great apes | 79 |
cynomolgus macaques | 79 |
close contact | 79 |
previously reported | 79 |
recent study | 79 |
human intestinal | 78 |
reverse transcription | 78 |
literature review | 78 |
efsa supporting | 78 |
rna polymerase | 78 |
cell viability | 78 |
cellular uptake | 78 |
supporting publication | 78 |
fusion protein | 78 |
cells expressing | 77 |
tumor necrosis | 77 |
another study | 77 |
cell membrane | 77 |
lassa fever | 77 |
antimicrobial peptide | 77 |
cell growth | 77 |
acid sequence | 77 |
disease outbreaks | 77 |
infected animals | 77 |
respiratory infection | 77 |
biological activity | 77 |
exogenous rnas | 77 |
human tissues | 77 |
critical role | 77 |
long term | 76 |
vascular endothelial | 76 |
amniotic fluid | 76 |
genome sequencing | 76 |
hek cells | 76 |
three different | 76 |
st century | 76 |
adhesion molecule | 76 |
potential role | 76 |
clinical manifestations | 76 |
hela cells | 76 |
risk management | 76 |
human infectious | 76 |
deficient mice | 75 |
cerebrospinal fluid | 75 |
cell wall | 75 |
exome sequencing | 75 |
zoonotic pathogens | 75 |
fetal growth | 75 |
may help | 75 |
bacterial infections | 75 |
human primates | 75 |
data indicate | 75 |
pseudomonas aeruginosa | 74 |
laboratory animals | 74 |
induced pluripotent | 74 |
social media | 74 |
results show | 74 |
recent advances | 74 |
drug discovery | 74 |
evolutionary biology | 74 |
defence peptides | 74 |
new human | 74 |
viral proteins | 74 |
derived extracellular | 74 |
diabetes mellitus | 74 |
one hand | 74 |
natural kind | 73 |
drug development | 73 |
species barrier | 73 |
structural proteins | 73 |
different cell | 73 |
genetic variants | 73 |
see table | 73 |
mast cells | 73 |
nucleotide sequence | 72 |
studies suggest | 72 |
stool samples | 72 |
open reading | 72 |
human blood | 72 |
airway epithelium | 72 |
recipient cells | 72 |
liquid chromatography | 72 |
viral genome | 72 |
viral diseases | 72 |
fi ndings | 72 |
high throughput | 71 |
may represent | 71 |
human adenovirus | 71 |
pulmonary disease | 71 |
brain injury | 71 |
ai systems | 71 |
tandem mass | 71 |
distress syndrome | 71 |
environmental factors | 71 |
years old | 71 |
time points | 71 |
birth weight | 71 |
statistically significant | 70 |
transplant recipients | 70 |
target genes | 70 |
like receptors | 70 |
last years | 70 |
candidate genes | 70 |
cardiovascular diseases | 70 |
plasma samples | 70 |
membrane protein | 70 |
rotavirus infection | 70 |
one study | 70 |
past years | 70 |
vaccinia virus | 70 |
heavy chain | 70 |
will also | 70 |
human viruses | 70 |
fatty acid | 70 |
whole genome | 69 |
fatality rate | 69 |
cohort study | 69 |
wide variety | 69 |
several studies | 69 |
cov infection | 69 |
analysis showed | 69 |
mononuclear cells | 69 |
studies using | 69 |
intestinal organoids | 69 |
cd cd | 69 |
significantly lower | 69 |
may cause | 68 |
foamy virus | 68 |
fi brosis | 68 |
human pancreatic | 68 |
severe respiratory | 68 |
hiv testing | 68 |
cell function | 68 |
infected individuals | 68 |
among children | 68 |
measles virus | 68 |
cleavage site | 68 |
immune cell | 68 |
small rnas | 67 |
dna repair | 67 |
congo hemorrhagic | 67 |
southeast asia | 67 |
leading cause | 67 |
fold increase | 67 |
emerging infections | 67 |
emerging diseases | 67 |
ang ii | 67 |
size exclusion | 67 |
helicobacter pylori | 66 |
acute gastroenteritis | 66 |
life cycle | 66 |
study design | 66 |
virus disease | 66 |
may occur | 66 |
adipose tissue | 66 |
rna sequencing | 66 |
human antibodies | 66 |
assay system | 66 |
domestic animals | 66 |
reservoir hosts | 66 |
south africa | 66 |
inflammatory responses | 66 |
low levels | 66 |
plasma levels | 66 |
protease inhibitors | 66 |
antibody fragments | 66 |
two groups | 66 |
human cancer | 65 |
serine protease | 65 |
life sciences | 65 |
viral pathogens | 65 |
clinical trial | 65 |
positive selection | 65 |
zoonotic transmission | 65 |
also used | 65 |
cells using | 65 |
binding proteins | 65 |
brain development | 65 |
healthy individuals | 64 |
cell carcinoma | 64 |
per day | 64 |
many cases | 64 |
high concentrations | 64 |
gel electrophoresis | 64 |
cord blood | 64 |
gonadal dysgenesis | 64 |
signifi cant | 64 |
cardiovascular disease | 64 |
binding domain | 64 |
crucial role | 64 |
will help | 64 |
simian foamy | 64 |
clinically relevant | 64 |
cell therapy | 64 |
ob gyn | 64 |
human antibody | 63 |
developed countries | 63 |
plasmodium falciparum | 63 |
single cell | 63 |
national institutes | 63 |
previously shown | 63 |
based tourism | 63 |
selective pressure | 63 |
guinea pig | 63 |
medical research | 63 |
culture system | 63 |
reverse transcriptase | 63 |
body fluids | 63 |
also present | 63 |
disease severity | 62 |
menstrual cycle | 62 |
human protein | 62 |
artificial intelligence | 62 |
human igg | 62 |
data show | 62 |
homo sapiens | 62 |
also observed | 62 |
affecting humans | 62 |
protein binding | 62 |
culture conditions | 62 |
vitro studies | 62 |
molecular basis | 62 |
japanese encephalitis | 62 |
drug administration | 62 |
campylobacter jejuni | 61 |
monkeypox virus | 61 |
stranded dna | 61 |
class i | 61 |
veterinary medicine | 61 |
specific genes | 61 |
increased expression | 61 |
blood vessels | 61 |
two major | 61 |
small molecules | 61 |
pancreatic cancer | 61 |
tunica albuginea | 61 |
linked glycans | 61 |
environmental health | 60 |
cause disease | 60 |
connective tissue | 60 |
human cell | 60 |
otitis media | 60 |
hepatocellular carcinoma | 60 |
total number | 60 |
structural characterization | 60 |
human development | 60 |
therapeutic potential | 60 |
well known | 60 |
cells may | 60 |
hematopoietic stem | 60 |
lymphocytic choriomeningitis | 59 |
first step | 59 |
membrane fusion | 59 |
host defense | 59 |
workplace technologies | 59 |
bacterial pathogens | 59 |
previously published | 59 |
liquid biopsy | 59 |
will continue | 59 |
rsv infection | 59 |
density gradient | 59 |
model system | 59 |
serum levels | 59 |
signaling pathway | 59 |
among others | 59 |
gene silencing | 59 |
biological fluids | 59 |
live attenuated | 59 |
study group | 59 |
human placenta | 59 |
vibrio cholerae | 59 |
disease caused | 58 |
brain barrier | 58 |
novel viruses | 58 |
two decades | 58 |
conditioned media | 58 |
inhibitory effect | 58 |
cells treated | 58 |
animal studies | 58 |
intrinsically disordered | 58 |
active site | 58 |
significantly decreased | 58 |
new host | 58 |
pulmonary syndrome | 58 |
male reproductive | 58 |
human testis | 58 |
clinical characteristics | 58 |
rhinovirus infection | 58 |
high prevalence | 58 |
higher levels | 58 |
reservoir host | 58 |
nonhuman primate | 58 |
will provide | 58 |
key words | 58 |
large numbers | 58 |
previously identified | 58 |
ion channel | 58 |
another example | 58 |
negative bacteria | 57 |
least two | 57 |
neutralizing antibody | 57 |
statistical analysis | 57 |
significantly different | 57 |
serum albumin | 57 |
haemorrhagic fever | 57 |
human cytomegalovirus | 57 |
vertical transmission | 57 |
pancreatic islets | 57 |
situ hybridization | 57 |
total observation | 57 |
two distinct | 57 |
ev isolation | 57 |
surface markers | 57 |
structural analysis | 57 |
also showed | 57 |
within days | 57 |
infection control | 57 |
future studies | 57 |
significant reduction | 57 |
lassa virus | 56 |
evidence suggests | 56 |
cell migration | 56 |
protein level | 56 |
much higher | 56 |
serum samples | 56 |
data analysis | 56 |
venezuelan equine | 56 |
disease risk | 56 |
size distribution | 56 |
general population | 56 |
trophoblast cells | 56 |
binding affinity | 56 |
defi ned | 56 |
angiotensin ii | 56 |
ionization mass | 56 |
similar results | 56 |
gives rise | 56 |
hantavirus pulmonary | 56 |
plant ncrnas | 56 |
genetic material | 56 |
income countries | 56 |
colon cancer | 56 |
significant difference | 56 |
central africa | 56 |
mechanisms underlying | 56 |
light chain | 56 |
dna sequence | 56 |
dna binding | 56 |
human norovirus | 56 |
nucleocapsid protein | 56 |
human life | 56 |
results demonstrate | 56 |
beta cells | 55 |
zoonotic infections | 55 |
ef fi | 55 |
chronic obstructive | 55 |
signalling pathways | 55 |
cytokine production | 55 |
new insights | 55 |
proteins involved | 55 |
differential expression | 55 |
testicular biopsy | 55 |
cell activation | 55 |
tumor cell | 55 |
molecular characterization | 55 |
human genetics | 55 |
times higher | 55 |
takes place | 55 |
food production | 55 |
serine proteases | 55 |
animal populations | 55 |
genetic variation | 54 |
drug delivery | 54 |
vivo studies | 54 |
kidney disease | 54 |
sars outbreak | 54 |
lentiviral vectors | 54 |
dromedary camels | 54 |
care unit | 54 |
high level | 54 |
south america | 54 |
decision making | 54 |
lung development | 54 |
norwalk virus | 54 |
food security | 54 |
tof tof | 54 |
early stage | 54 |
also identified | 54 |
rhesus monkeys | 54 |
pathogenic bacteria | 54 |
human tfr | 54 |
potential therapeutic | 54 |
bile acid | 54 |
beneficial effects | 54 |
mental retardation | 54 |
clinical studies | 54 |
studies showed | 54 |
fusion proteins | 54 |
zoonotic spillover | 54 |
transgenic mouse | 54 |
tissue tropism | 54 |
better understand | 54 |
special issue | 54 |
natural reservoir | 54 |
cancer therapy | 54 |
intermediate host | 53 |
reading frames | 53 |
cell receptor | 53 |
age groups | 53 |
two types | 53 |
clostridium difficile | 53 |
cell populations | 53 |
lamina propria | 53 |
controlled trial | 53 |
acid residues | 53 |
infectious virus | 53 |
speci fi | 53 |
wild birds | 53 |
many countries | 53 |
oral route | 53 |
healthy controls | 53 |
intellectual disability | 53 |
among humans | 53 |
human liver | 53 |
health systems | 53 |
increased levels | 53 |
one another | 52 |
new viruses | 52 |
digital human | 52 |
epidermal growth | 52 |
living beings | 52 |
new technologies | 52 |
preterm delivery | 52 |
coronavirus hku | 52 |
tumour cells | 52 |
proinflammatory cytokines | 52 |
viruses may | 52 |
uniprot id | 52 |
biological processes | 52 |
will require | 52 |
conditioned medium | 52 |
might also | 52 |
rna genome | 52 |
terminal domain | 52 |
free radical | 52 |
lung disease | 52 |
hospitalized children | 52 |
intestinal tract | 52 |
pathogenic viruses | 52 |
prospective study | 52 |
obstructive pulmonary | 52 |
chemically modified | 52 |
culture systems | 52 |
preterm birth | 52 |
autosomal recessive | 52 |
newly identified | 51 |
twentieth century | 51 |
i will | 51 |
vas deferens | 51 |
many years | 51 |
lung epithelial | 51 |
antibody therapy | 51 |
clinical samples | 51 |
early detection | 51 |
biological effects | 51 |
reading frame | 51 |
years later | 51 |
samples collected | 51 |
antiviral drugs | 51 |
strand breaks | 51 |
farm animals | 51 |
cynomolgus monkeys | 51 |
intercellular communication | 51 |
reverse genetics | 51 |
evolutionary medicine | 51 |
like cells | 51 |
viral particles | 51 |
analysis using | 51 |
fruit bat | 51 |
immunocompromised patients | 51 |
high degree | 51 |
vitro model | 51 |
based therapies | 51 |
cells derived | 51 |
authors declare | 51 |
organoids derived | 51 |
cell responses | 51 |
single nucleotide | 51 |
coronavirus nl | 50 |
diarrheal disease | 50 |
neurodegenerative diseases | 50 |
many different | 50 |
bronchoalveolar lavage | 50 |
fl uid | 50 |
weight gain | 50 |
negative ion | 50 |
brain tissue | 50 |
new zealand | 50 |
cystic fi | 50 |
hybridoma technology | 50 |
functional ingredients | 50 |
bronchial epithelial | 50 |
research institute | 50 |
genome editing | 50 |
coupled receptors | 50 |
red blood | 50 |
determined using | 50 |
tyrosine kinase | 50 |
primary cells | 50 |
cell tumor | 50 |
interspecies transmission | 50 |
old world | 50 |
sequence data | 50 |
genetic engineering | 50 |
highly expressed | 49 |
genome project | 49 |
fecal samples | 49 |
infl ammatory | 49 |
mortality rates | 49 |
insulin resistance | 49 |
gene regulation | 49 |
time rt | 49 |
ca i | 49 |
density lipoprotein | 49 |
comparative analysis | 49 |
growth restriction | 49 |
isolated using | 49 |
glycosylation sites | 49 |
health risks | 49 |
case fatality | 49 |
central african | 49 |
coronavirus infections | 49 |
positive cells | 49 |
septic shock | 49 |
pharmakologie und | 49 |
drug targets | 49 |
broad range | 49 |
coupled receptor | 49 |
reporter gene | 49 |
choriomeningitis virus | 49 |
rheumatoid arthritis | 49 |
immune function | 49 |
bacterial species | 49 |
genetically engineered | 49 |
experimental infection | 49 |
linked immunosorbent | 49 |
current study | 48 |
acid sequences | 48 |
developing world | 48 |
differential ultracentrifugation | 48 |
candida albicans | 48 |
less likely | 48 |
alveolar epithelial | 48 |
spike glycoprotein | 48 |
healthy adults | 48 |
occupational health | 48 |
tumor suppressor | 48 |
may explain | 48 |
sequence similarity | 48 |
remains unclear | 48 |
alternative splicing | 48 |
case study | 48 |
hulless barley | 48 |
several different | 48 |
higher risk | 48 |
may affect | 48 |
cell population | 48 |
human breast | 48 |
renal failure | 48 |
rna interference | 48 |
virulence factors | 48 |
confirmed cases | 48 |
precocious puberty | 48 |
pulmonary fibrosis | 48 |
virus particles | 48 |
vascular smooth | 48 |
passive immunization | 48 |
fetal membranes | 48 |
southern china | 48 |
enzyme activity | 48 |
animal diseases | 48 |
virus transmission | 48 |
fi nding | 48 |
virus isolated | 48 |
whole blood | 47 |
immunosorbent assay | 47 |
much less | 47 |
immune globulin | 47 |
genome sequences | 47 |
see also | 47 |
human subjects | 47 |
antibody response | 47 |
emerging pathogens | 47 |
antibody responses | 47 |
expression pattern | 47 |
control study | 47 |
infl ammation | 47 |
possible role | 47 |
terminal region | 47 |
people living | 47 |
expression analysis | 47 |
epidemiological studies | 47 |
structural determination | 47 |
emerging zoonoses | 47 |
major role | 47 |
infectious agent | 47 |
bocavirus infection | 47 |
human cd | 47 |
may serve | 47 |
future research | 47 |
treated cells | 47 |
heart rate | 47 |
male infertility | 47 |
und toxikologie | 47 |
pathogen transmission | 47 |
small extracellular | 47 |
limited number | 47 |
measured using | 47 |
flight mass | 46 |
disease surveillance | 46 |
human tissue | 46 |
ion channels | 46 |
chikungunya virus | 46 |
land use | 46 |
intermediate hosts | 46 |
rna molecules | 46 |
host interactions | 46 |
cause severe | 46 |
respiratory pathogens | 46 |
human interferon | 46 |
dna sequences | 46 |
small animal | 46 |
population growth | 46 |
protein content | 46 |
humanized mouse | 46 |
genomic dna | 46 |
androgen insensitivity | 46 |
acute phase | 46 |
human myometrium | 46 |
exogenous plant | 46 |
host population | 46 |
tumor growth | 46 |
tissue samples | 46 |
inflammatory cytokine | 46 |
factor receptor | 46 |
antimicrobial agents | 46 |
streptococcus pneumoniae | 46 |
health emergency | 46 |
gene encoding | 46 |
preterm labor | 46 |
airway organoids | 46 |
lymphoid cells | 46 |
contaminated water | 46 |
using different | 46 |
global public | 46 |
clinical use | 46 |
functional analysis | 46 |
viral loads | 46 |
resistant bacteria | 46 |
national institute | 46 |
heat shock | 45 |
membrane proteins | 45 |
human virome | 45 |
pathogen interactions | 45 |
hmpv infection | 45 |
organoid cultures | 45 |
i interferon | 45 |
cultured human | 45 |
human beta | 45 |
urine samples | 45 |
cell biology | 45 |
regenerative medicine | 45 |
immune systems | 45 |
human evolution | 45 |
national security | 45 |
inflammatory bowel | 45 |
cell communication | 45 |
personalized medicine | 45 |
logistic regression | 45 |
cesarean section | 45 |
natural environment | 45 |
therapeutic agents | 45 |
virus isolation | 45 |
pregnant rats | 44 |
ev markers | 44 |
receptor expression | 44 |
testicular descent | 44 |
enzymatic activity | 44 |
human genes | 44 |
environmental conditions | 44 |
pandemic potential | 44 |
modern humans | 44 |
also play | 44 |
genetic analysis | 44 |
autosomal dominant | 44 |
health problems | 44 |
living cells | 44 |
particle size | 44 |
weeks gestation | 44 |
critically ill | 44 |
central role | 44 |
high mortality | 44 |
ecosystem services | 44 |
human insulin | 44 |
giant cells | 44 |
polyclonal antibodies | 44 |
every year | 44 |
virus isolates | 44 |
male pseudohermaphroditism | 44 |
risk groups | 44 |
evs derived | 44 |
hypogonadotropic hypogonadism | 44 |
small number | 44 |
recombinant proteins | 44 |
viral shedding | 44 |
democratic republic | 44 |
university medical | 44 |
human gene | 44 |
virus strains | 44 |
isolated evs | 44 |
respiratory diseases | 44 |
creative commons | 44 |
important roles | 44 |
known human | 44 |
spillover events | 44 |
clinical applications | 44 |
fi cient | 43 |
cardiac hypertrophy | 43 |
viral entry | 43 |
cell fate | 43 |
platelet activation | 43 |
essential role | 43 |
differential diagnosis | 43 |
androgen receptor | 43 |
toxoplasma gondii | 43 |
confocal microscopy | 43 |
gene products | 43 |
nuclear transfer | 43 |
european union | 43 |
receptor gene | 43 |
human consumption | 43 |
influenza infection | 43 |
like structures | 43 |
fully understood | 43 |
ev cargo | 43 |
highly sensitive | 43 |
protective effect | 43 |
target cell | 43 |
caenorhabditis elegans | 43 |
fi bers | 43 |
cells showed | 43 |
cells via | 43 |
genes encoding | 43 |
like virus | 43 |
natural kinds | 43 |
three times | 43 |
cell development | 43 |
animal reservoirs | 43 |
surface proteins | 43 |
mouse brain | 43 |
listeria monocytogenes | 43 |
natural host | 43 |
first isolated | 43 |
respiratory viral | 43 |
ms analysis | 43 |
dna viruses | 43 |
research council | 43 |
hydrogen peroxide | 43 |
kg bw | 42 |
current status | 42 |
natural history | 42 |
gene family | 42 |
emerging zoonotic | 42 |
east asia | 42 |
person transmission | 42 |
directed differentiation | 42 |
mice infected | 42 |
protective effects | 42 |
wildlife species | 42 |
short term | 42 |
therapeutic strategies | 42 |
many people | 42 |
biological effect | 42 |
become infected | 42 |
urinary tract | 42 |
type mice | 42 |
control strategies | 42 |
laboratory animal | 42 |
cellular processes | 42 |
murine model | 42 |
random forest | 42 |
cotton rats | 42 |
phase i | 42 |
social distancing | 42 |
expression level | 42 |
working group | 42 |
infection among | 42 |
avian viruses | 42 |
chronic fatigue | 42 |
borne viruses | 42 |
human umbilical | 42 |
viral protein | 42 |
cell survival | 42 |
located within | 42 |
also reported | 42 |
class ii | 42 |
exogenous rna | 42 |
bowel disease | 42 |
world war | 42 |
traumatic brain | 42 |
specific antibody | 42 |
dose dependent | 42 |
small molecule | 42 |
cell entry | 42 |
cd cells | 42 |
human configurations | 42 |
african green | 42 |
take place | 42 |
external genitalia | 41 |
basal cells | 41 |
hepatitis virus | 41 |
display library | 41 |
comparative study | 41 |
binding properties | 41 |
children hospitalized | 41 |
natural reservoirs | 41 |
activated protein | 41 |
therapeutic applications | 41 |
new therapeutic | 41 |
diseases caused | 41 |
ev release | 41 |
relatively high | 41 |
including humans | 41 |
infecting humans | 41 |
serum therapy | 41 |
parainfluenza virus | 41 |
cell division | 41 |
short stature | 41 |
reproductive tissue | 41 |
study showed | 41 |
across species | 41 |
still unknown | 41 |
ion mode | 41 |
aedes aegypti | 41 |
current knowledge | 41 |
substrate specificity | 41 |
coronavirus oc | 41 |
cancer research | 41 |
drug screening | 41 |
like illness | 41 |
expression patterns | 41 |
antibiotic use | 41 |
mouth disease | 41 |
starting point | 41 |
recombinant antibodies | 41 |
scientific community | 41 |
isolation methods | 41 |
economic impact | 41 |
target proteins | 41 |
human society | 41 |
developmental delay | 41 |
early pregnancy | 41 |
laboratory mice | 40 |
will allow | 40 |
prairie dogs | 40 |
currently available | 40 |
analyzed using | 40 |
first described | 40 |
fat diet | 40 |
differential centrifugation | 40 |
virus vaccine | 40 |
tissue engineering | 40 |
wide association | 40 |
genes associated | 40 |
newly discovered | 40 |
human clinical | 40 |
specific expression | 40 |
time point | 40 |
year old | 40 |
control mice | 40 |
molecular mechanism | 40 |
identified using | 40 |
low concentrations | 40 |
hiv transmission | 40 |
health services | 40 |
results showed | 40 |
wild animal | 40 |
also shown | 40 |
global burden | 40 |
rat model | 40 |
cellular receptor | 40 |
protein complexes | 40 |
human ace | 40 |
west african | 40 |
fatigue syndrome | 40 |
ko mice | 40 |
ace receptor | 40 |
may become | 40 |
positive control | 40 |
bovine serum | 40 |
ocular surface | 40 |
surface protein | 40 |
international committee | 40 |
neuronal cells | 40 |
therapeutic targets | 40 |
data sets | 40 |
genetic background | 40 |
fully human | 40 |
heparan sulfate | 39 |
human adult | 39 |
inflammatory diseases | 39 |
economic development | 39 |
human factors | 39 |
van den | 39 |
human fetal | 39 |
influenza strains | 39 |
marburg virus | 39 |
last decade | 39 |
relatively low | 39 |
molecular epidemiology | 39 |
natural resources | 39 |
somatic cell | 39 |
respiratory symptoms | 39 |
association studies | 39 |
squamous cell | 39 |
throughput screening | 39 |
mental health | 39 |
respiratory secretions | 39 |
human leukocyte | 39 |
preliminary data | 39 |
testicular microlithiasis | 39 |
broad spectrum | 39 |
elevated levels | 39 |
barley grains | 39 |
dendritic cell | 39 |
adenovirus type | 39 |
evs isolated | 39 |
vaccine candidates | 39 |
adult mice | 39 |
viral respiratory | 39 |
tissue sections | 39 |
gastric cancer | 39 |
pcr assay | 39 |
domestic violence | 39 |
human rhinoviruses | 39 |
capsid protein | 39 |
total protein | 39 |
emerging viral | 39 |
human parvovirus | 39 |
early stages | 39 |
healthy volunteers | 39 |
haemophilus influenzae | 39 |
significant changes | 39 |
eu publications | 39 |
medical school | 39 |
also detected | 39 |
vice versa | 39 |
dengue fever | 39 |
social workers | 39 |
receptor specificity | 39 |
persistent infection | 39 |
antimicrobial therapy | 39 |
publications efsa | 39 |
mediated gene | 38 |
quality control | 38 |
retinoic acid | 38 |
giving rise | 38 |
coronavirus associated | 38 |
early diagnosis | 38 |
evolutionary history | 38 |
may develop | 38 |
acquired pneumonia | 38 |
ill patients | 38 |
domesticated animals | 38 |
neurological disorders | 38 |
mers coronavirus | 38 |
organ tropisms | 38 |
dna polymerase | 38 |
near future | 38 |
messenger rna | 38 |
common ancestor | 38 |
ulcerative colitis | 38 |
bile acids | 38 |
two main | 38 |
copy number | 38 |
superoxide dismutase | 38 |
van der | 38 |
proteomic analysis | 38 |
wastewater treatment | 38 |
blood mononuclear | 38 |
coding genes | 38 |
results obtained | 38 |
largely unknown | 38 |
basement membrane | 38 |
cholera toxin | 38 |
viral antigens | 38 |
infected humans | 38 |
disordered regions | 38 |
chemical synthesis | 38 |
children human | 38 |
endothelial growth | 38 |
healthy donors | 38 |
viral disease | 38 |
bacterial infection | 38 |
target gene | 38 |
like viruses | 38 |
point mutations | 38 |
provide evidence | 38 |
adhesion molecules | 38 |
among different | 38 |
protective immunity | 38 |
frequently used | 38 |
significant decrease | 38 |
room temperature | 38 |
classifi cation | 38 |
pivotal role | 38 |
last two | 38 |
new coronavirus | 38 |
data collection | 38 |
newly emerging | 38 |
several years | 37 |
ace expression | 37 |
robot interaction | 37 |
host factors | 37 |
healthy subjects | 37 |
cells within | 37 |
may act | 37 |
animal abuse | 37 |
adult human | 37 |
sore throat | 37 |
health problem | 37 |
pediatric patients | 37 |
brain organoids | 37 |
lymphotropic virus | 37 |
cervical ripening | 37 |
nuclear factor | 37 |
small size | 37 |
high frequency | 37 |
naked sirna | 37 |
yersinia pestis | 37 |
molecular cloning | 37 |
phosphorylation sites | 37 |
organoid culture | 37 |
fold change | 37 |
time course | 37 |
host response | 37 |
tissue damage | 37 |
evs released | 37 |
transgenic animals | 37 |
also demonstrated | 37 |
may include | 37 |
killer cells | 37 |
spongiform encephalopathy | 37 |
mediated endocytosis | 37 |
signalling pathway | 37 |
chemokine receptor | 37 |
genetic variability | 37 |
genetic information | 37 |
north american | 37 |
bl mice | 37 |
membrane vesicles | 37 |
fetal brain | 37 |
human pathogen | 37 |
adrenal hyperplasia | 37 |
therapeutic target | 37 |
energy extraction | 37 |
gene ontology | 37 |
well established | 37 |
small intestinal | 37 |
systems biology | 37 |
based therapeutics | 37 |
related genes | 37 |
experimental animals | 37 |
data demonstrate | 37 |
paneth cells | 36 |
primary cell | 36 |
significantly associated | 36 |
reported cases | 36 |
rhesus macaque | 36 |
billion people | 36 |
uenza virus | 36 |
human induced | 36 |
significant role | 36 |
muscular dystrophy | 36 |
passive immunotherapy | 36 |
data suggests | 36 |
predictive value | 36 |
human mabs | 36 |
cardiac function | 36 |
tissue distribution | 36 |
increasing evidence | 36 |
large amounts | 36 |
pcr assays | 36 |
sequence identity | 36 |
human corneal | 36 |
membrane potential | 36 |
whole exome | 36 |
tof mass | 36 |
norovirus infection | 36 |
cell clones | 36 |
neurological disease | 36 |
two species | 36 |
rna synthesis | 36 |
life expectancy | 36 |
mesenchymal cells | 36 |
order effects | 36 |
umbilical vein | 36 |
viruses isolated | 36 |
two novel | 36 |
ciliated cells | 36 |
mammalian species | 36 |
lower levels | 36 |
personal autonomy | 36 |
major histocompatibility | 36 |
zoonotic potential | 36 |
social networks | 36 |
joint action | 36 |
physiological conditions | 36 |
borne encephalitis | 36 |
mechanisms involved | 36 |
natural products | 36 |
culture models | 36 |
women undergoing | 36 |
th cells | 36 |
clinical practice | 36 |
emerging disease | 36 |
health approach | 36 |
large scale | 36 |
hospitalized patients | 36 |
receptor activation | 36 |
rural areas | 36 |
surface area | 36 |
investigate whether | 36 |
subcellular localization | 36 |
human activities | 36 |
showed significant | 36 |
double strand | 36 |
orally administered | 36 |
many viruses | 35 |
pattern recognition | 35 |
dna replication | 35 |
antibody repertoire | 35 |
cd expression | 35 |
different countries | 35 |
chain variable | 35 |
functional role | 35 |
population density | 35 |
model organisms | 35 |
corneal epithelial | 35 |
assessed using | 35 |
embryonic development | 35 |
health security | 35 |
lung organoids | 35 |
different stages | 35 |
intravenous immunoglobulin | 35 |
clinical data | 35 |
novel virus | 35 |
phase ii | 35 |
linked glycosylation | 35 |
human rotavirus | 35 |
human colostrum | 35 |
university school | 35 |
one example | 35 |
related diseases | 35 |
treated animals | 35 |
oral cavity | 35 |
world bank | 35 |
vast majority | 35 |
zoster virus | 35 |
rodent models | 35 |
fatal disease | 35 |
adult humans | 35 |
viral dna | 35 |
studies revealed | 35 |
inhibitory activity | 35 |
major cause | 35 |
induced apoptosis | 35 |
one species | 35 |
green monkeys | 35 |
literature search | 35 |
long time | 35 |
social network | 35 |
ai ethics | 35 |
disease outbreak | 35 |
new drugs | 35 |
pdb id | 35 |
analysed using | 35 |
different mechanisms | 35 |
air travel | 35 |
powerful tool | 35 |
airborne transmission | 35 |
gene transcription | 35 |
per cell | 35 |
data obtained | 35 |
sars virus | 35 |
body mass | 35 |
social work | 35 |
drug binding | 35 |
contaminated food | 35 |
immunodefi ciency | 35 |
respiratory epithelium | 35 |
human animals | 35 |
liver disease | 35 |
virus entry | 35 |
expression profiles | 35 |
based approach | 35 |
lung tissues | 35 |
intestinal epithelial | 34 |
intestinal microbiota | 34 |
brain regions | 34 |
mesenchymal stromal | 34 |
high resolution | 34 |
magnetic resonance | 34 |
acute infection | 34 |
diffi cult | 34 |
bat species | 34 |
pig model | 34 |
pet ownership | 34 |
ethical issues | 34 |
human hosts | 34 |
disease modeling | 34 |
mouse strains | 34 |
myocardial infarction | 34 |
expressing cells | 34 |
scientific research | 34 |
potential use | 34 |
clinical outcome | 34 |
environmental changes | 34 |
key questions | 34 |
virus genome | 34 |
fetal lung | 34 |
successfully used | 34 |
lung cells | 34 |
disease virus | 34 |
plasma cells | 34 |
chronic disease | 34 |
natural hosts | 34 |
adenovirus infection | 34 |
ebola outbreak | 34 |
cow milk | 34 |
spermatic cord | 34 |
studies will | 34 |
associated protein | 34 |
functional studies | 34 |
patients infected | 34 |
will need | 34 |
sustainable development | 34 |
age group | 34 |
using human | 34 |
factors associated | 34 |
cryptorchid testes | 34 |
wt mice | 34 |
indirect contact | 34 |
experimental models | 34 |
first report | 34 |
enveloped viruses | 34 |
help us | 34 |
human ifn | 34 |
antibodies directed | 34 |
antibodies specific | 34 |
plasma evs | 34 |
york city | 34 |
intestinal mucosa | 34 |
mhc class | 34 |
examples include | 34 |
well understood | 34 |
life science | 34 |
first reported | 34 |
binding residues | 34 |
sanger sequencing | 34 |
highly variable | 34 |
endemic areas | 34 |
ev subpopulations | 34 |
therapeutic antibodies | 33 |
using two | 33 |
quantitative real | 33 |
must also | 33 |
molecularly imprinted | 33 |
first months | 33 |
pilot study | 33 |
novel therapeutic | 33 |
acute otitis | 33 |
nineteenth century | 33 |
see section | 33 |
acute lower | 33 |
kg day | 33 |
pathway analysis | 33 |
like particles | 33 |
risk group | 33 |
may suggest | 33 |
studies indicate | 33 |
infertile men | 33 |
health effects | 33 |
mitochondrial membrane | 33 |
dietary intake | 33 |
healthy human | 33 |
enteric pathogens | 33 |
associated proteins | 33 |
cell hyperplasia | 33 |
renal function | 33 |
folic acid | 33 |
single chain | 33 |
high fat | 33 |
granulosa cells | 33 |
tof analysis | 33 |
although many | 33 |
neurological diseases | 33 |
whole grains | 33 |
histocompatibility complex | 33 |
rna binding | 33 |
virus encephalitis | 33 |
biological activities | 33 |
urgent need | 33 |
platelet aggregation | 33 |
young adults | 33 |
increasing number | 33 |
recent report | 33 |
animal hosts | 33 |
microbial communities | 33 |
homologous recombination | 33 |
traditional security | 33 |
inflammatory mediators | 33 |
like symptoms | 33 |
urban areas | 33 |
guangdong province | 33 |
expressing human | 33 |
also cause | 33 |
patients undergoing | 33 |
hiv prevention | 33 |
cells also | 33 |
barrier function | 33 |
necrotizing enterocolitis | 33 |
defi cit | 33 |
first identified | 33 |
adaptive immunity | 33 |
liver cancer | 33 |
blood cell | 33 |
great potential | 32 |
pulmonary hypertension | 32 |
mice showed | 32 |
also provide | 32 |
small cell | 32 |
microarray analysis | 32 |
causes severe | 32 |
reproductive cloning | 32 |
signi fi | 32 |
disease burden | 32 |
maternal plasma | 32 |
antiviral agents | 32 |
exosomes derived | 32 |
global spread | 32 |
national research | 32 |
animal origin | 32 |
three groups | 32 |
population size | 32 |
cell transformation | 32 |
great ape | 32 |
broadly neutralizing | 32 |
basic research | 32 |
hrv infection | 32 |
health implications | 32 |
patients suffering | 32 |
antibody production | 32 |
social isolation | 32 |
virus strain | 32 |
clinical presentation | 32 |
high quality | 32 |
identifi cation | 32 |
global warming | 32 |
sickle cell | 32 |
dromedary mers | 32 |
protease inhibitor | 32 |
molecular analysis | 32 |
specific cell | 32 |
clinical outcomes | 32 |
recombinant dna | 32 |
oral transmission | 32 |
transgenic pigs | 32 |
per se | 32 |
human placental | 32 |
often used | 32 |
interaction network | 32 |
protein sequences | 32 |
human endometrium | 32 |
days post | 32 |
economic growth | 32 |
seasonal influenza | 32 |
cigarette smoke | 32 |
control animals | 32 |
quantitative analysis | 32 |
single dose | 32 |
causative agents | 32 |
strand rna | 32 |
emerging human | 32 |
infection may | 32 |
relatively small | 32 |
supplementary table | 32 |
lymph node | 32 |
human colon | 32 |
pandemic risk | 32 |
biological functions | 32 |
virus may | 32 |
multiple species | 32 |
risk communication | 32 |
associated coronavirus | 32 |
recently identified | 32 |
endangered species | 32 |
family history | 32 |
molecular evolution | 32 |
eukaryotic cells | 32 |
mutation rate | 32 |
fatal cases | 32 |
immune deficiency | 32 |
occupational diseases | 32 |
diagnostic tests | 32 |
hiv status | 32 |
coronavirus spike | 32 |
disease models | 32 |
arabidopsis thaliana | 32 |
ml min | 32 |
respiratory failure | 32 |
testicular parenchyma | 32 |
glycan structures | 32 |
preliminary results | 32 |
response element | 32 |
adult stem | 32 |
stress response | 32 |
mammalian cell | 31 |
borrelia burgdorferi | 31 |
dna double | 31 |
million deaths | 31 |
bat origin | 31 |
population genetics | 31 |
solid tumors | 31 |
surface antigen | 31 |
structural basis | 31 |
respiratory droplets | 31 |
quantitative pcr | 31 |
physiological functions | 31 |
delivery systems | 31 |
positive ion | 31 |
residues tof | 31 |
nucleotide sequences | 31 |
cultured cells | 31 |
molecular recognition | 31 |
cell response | 31 |
sequence homology | 31 |
sinapinic acid | 31 |
small evs | 31 |
swine influenza | 31 |
protein cargo | 31 |
remains unknown | 31 |
described previously | 31 |
health measures | 31 |
humans may | 31 |
translational research | 31 |
statistical significance | 31 |
atopic dermatitis | 31 |
also increased | 31 |
another important | 31 |
replacement therapy | 31 |
cell numbers | 31 |
microvascular endothelial | 31 |
related viruses | 31 |
high rate | 31 |
cell identity | 31 |
days postinfection | 31 |
negative control | 31 |
electrochemical sensor | 31 |
protein kinases | 31 |
social norms | 31 |
dependent rna | 31 |
functional characterization | 31 |
primate species | 31 |
genetic basis | 31 |
sexually transmitted | 31 |
biological samples | 31 |
recently emerged | 31 |
much lower | 31 |
luciferase reporter | 31 |
cell signaling | 31 |
structural information | 31 |
envelope protein | 31 |
primary infection | 31 |
therapeutic efficacy | 31 |
may increase | 31 |
related proteins | 31 |
coding rnas | 31 |
gene segments | 31 |
surface receptor | 31 |
avian flu | 31 |
endogenous retroviruses | 31 |
widely accepted | 31 |
different human | 31 |
domestic cat | 31 |
adrenergic receptor | 31 |
hemorrhagic fevers | 31 |
effective treatment | 31 |
surface marker | 31 |
uric acid | 31 |
human monkeypox | 31 |
human endothelial | 31 |
estrogen receptor | 31 |
promoter activity | 31 |
humoral immune | 31 |
early childhood | 31 |
association study | 31 |
shed light | 31 |
low molecular | 31 |
animal cell | 31 |
cytomegalovirus infection | 31 |
los angeles | 31 |
based approaches | 31 |
many studies | 31 |
bodily fluids | 31 |
psychological stress | 31 |
population level | 31 |
preventive measures | 31 |
also occur | 31 |
liver injury | 31 |
latin america | 31 |
will lead | 31 |
biologically active | 31 |
human herpesvirus | 31 |
immune serum | 31 |
studies show | 31 |
signifi cantly | 31 |
three viruses | 31 |
various types | 31 |
mass index | 31 |
may prove | 31 |
neutralizing activity | 31 |
will become | 31 |
transmission dynamics | 31 |
display libraries | 31 |
aag levels | 31 |
security council | 31 |
bovine spongiform | 31 |
major human | 31 |
particular interest | 31 |
etiological agent | 31 |
bovine tuberculosis | 31 |
showed increased | 31 |
poor prognosis | 30 |
animal care | 30 |
shiga toxin | 30 |
human exposure | 30 |
human organoids | 30 |
dependent protein | 30 |
protein sequence | 30 |
acm device | 30 |
cell subsets | 30 |
two patients | 30 |
saccharomyces cerevisiae | 30 |
significant number | 30 |
will likely | 30 |
ciency virus | 30 |
state security | 30 |
dna sequencing | 30 |
might contribute | 30 |
culture supernatants | 30 |
health benefits | 30 |
living systems | 30 |
cell membranes | 30 |
human origin | 30 |
innate lymphoid | 30 |
human bronchial | 30 |
low birth | 30 |
foamy viruses | 30 |
human samples | 30 |
maternal blood | 30 |
three types | 30 |
food supply | 30 |
receptor antagonist | 30 |
health hazards | 30 |
arabian peninsula | 30 |
spin trapping | 30 |
sample preparation | 30 |
highly susceptible | 30 |
human chromosome | 30 |
cell receptors | 30 |
also associated | 30 |
inhibitory effects | 30 |
likely due | 30 |
life span | 30 |
chapter iv | 30 |
es cells | 30 |
creatine supplementation | 30 |
simian immunodeficiency | 30 |
severe cases | 30 |
biological systems | 30 |
viral agents | 30 |
south korea | 30 |
vaccine candidate | 30 |
human well | 30 |
medical care | 30 |
structural identification | 30 |
toxic effects | 30 |
decidual cells | 30 |
intestinal epithelium | 30 |
kidney cells | 30 |
microbial threats | 30 |
premature infants | 30 |
somatic cells | 30 |
transcriptional regulation | 30 |
febrile illness | 30 |
maternal antibodies | 30 |
lessons learned | 30 |
animal reservoir | 30 |
made available | 30 |
sequence alignment | 30 |
human medicine | 30 |
tract illness | 30 |
infection model | 30 |
carcinoma cells | 30 |
high sensitivity | 30 |
member states | 30 |
mechanical ventilation | 30 |
different levels | 30 |
readily available | 30 |
therapeutic effect | 30 |
structural features | 30 |
naturally infected | 30 |
dawley rats | 30 |
ionization time | 30 |
gene product | 30 |
precision medicine | 30 |
various cell | 30 |
human alpha | 30 |
new species | 29 |
acid substitutions | 29 |
electron microscopic | 29 |
wistar rats | 29 |
seq data | 29 |
environmental change | 29 |
study human | 29 |
protective efficacy | 29 |
type iv | 29 |
based methods | 29 |
borne disease | 29 |
quantitative rt | 29 |
airway epithelia | 29 |
therapeutic intervention | 29 |
organ transplantation | 29 |
lung diseases | 29 |
salmonella typhimurium | 29 |
tumour microenvironment | 29 |
seminal plasma | 29 |
cardiac fibroblasts | 29 |
positively charged | 29 |
probably due | 29 |
resistant strains | 29 |
intellectual property | 29 |
acute diarrhea | 29 |
feline infectious | 29 |
alveolar macrophages | 29 |
lesser extent | 29 |
secretory phase | 29 |
dietary supplementation | 29 |
virus species | 29 |
transient receptor | 29 |
using crispr | 29 |
protective equipment | 29 |
common cause | 29 |
carrying capacity | 29 |
mast cell | 29 |
mouse ifn | 29 |
one patient | 29 |
sex workers | 29 |
ev production | 29 |
ischemic stroke | 29 |
also important | 29 |
human endometrial | 29 |
kinase inhibitor | 29 |
human tumor | 29 |
separation capillary | 29 |
cerebral organoids | 29 |
messenger rnas | 29 |
cell derived | 29 |
rna expression | 29 |
human species | 29 |
protein markers | 29 |
global trends | 29 |
four different | 29 |
nonstructural protein | 29 |
potential risk | 29 |
bovine milk | 29 |
infection human | 29 |
envelope glycoprotein | 29 |
findings indicate | 29 |
negatively charged | 29 |
first human | 29 |
negative effects | 29 |
directed mutagenesis | 29 |
virus detection | 29 |
international health | 29 |
human pancreas | 29 |
nsp protein | 29 |
goblet cells | 29 |
genetic changes | 29 |
two years | 29 |
plasma volume | 29 |
dna adducts | 29 |
viral hemorrhagic | 29 |
clinical relevance | 29 |
antigen receptor | 29 |
ecological niche | 29 |
human monocytes | 29 |
gold standard | 29 |
based assays | 29 |
human interface | 29 |
acute lung | 29 |
interstitial pneumonia | 29 |
full length | 29 |
surface receptors | 29 |
placental tissue | 29 |
programmed cell | 29 |
many others | 29 |
well characterized | 29 |
eoc cells | 29 |
oral delivery | 29 |
human behavior | 29 |
several species | 29 |
tumour growth | 29 |
carcinoma cell | 29 |
scientific knowledge | 29 |
sensory neurons | 29 |
mucosal immune | 29 |
treated mice | 29 |
experimentally infected | 29 |
fi ciency | 29 |
million years | 29 |
disease model | 29 |
pcr analysis | 29 |
one third | 29 |
plasma concentrations | 29 |
testicular biopsies | 29 |
data set | 29 |
receptor potential | 29 |
animal products | 29 |
glucose tolerance | 29 |
infectious peritonitis | 29 |
water management | 29 |
cell tropism | 29 |
performance liquid | 29 |
viral vectors | 29 |
universal declaration | 29 |
conformational changes | 28 |
positive samples | 28 |
factors may | 28 |
intrauterine growth | 28 |
competing interests | 28 |
human adaptation | 28 |
companion animal | 28 |
branching morphogenesis | 28 |
classifi ed | 28 |
testicular cancer | 28 |
breastfed infants | 28 |
recently reported | 28 |
like coronaviruses | 28 |
recognition receptors | 28 |
infectious bronchitis | 28 |
nosocomial transmission | 28 |
spreader nodes | 28 |
protein coupled | 28 |
infect human | 28 |
mass spectrometer | 28 |
virus human | 28 |
fi brous | 28 |
clinical diagnosis | 28 |
medical ethics | 28 |
expression profile | 28 |
disordered proteins | 28 |
frequently associated | 28 |
previously unrecognized | 28 |
control cells | 28 |
severe pneumonia | 28 |
healthcare workers | 28 |
children younger | 28 |
snake venom | 28 |
may vary | 28 |
human studies | 28 |
gave rise | 28 |
cause human | 28 |
major source | 28 |
inflammatory disease | 28 |
primary tissue | 28 |
silver nanoparticles | 28 |
standard deviation | 28 |
using real | 28 |
nonstructural proteins | 28 |
fetal plasma | 28 |
activation ph | 28 |
airway smooth | 28 |
environmental protection | 28 |
cancer organoids | 28 |
chinese hamster | 28 |
active surveillance | 28 |
treatment options | 28 |
evolutionary biologists | 28 |
three major | 28 |
horseshoe bats | 28 |
alveolar damage | 28 |
modern human | 28 |
recent data | 28 |
insulin levels | 28 |
san francisco | 28 |
play important | 28 |
bladder cancer | 28 |
infected mice | 28 |
among women | 28 |
health system | 28 |
asymptomatic infections | 28 |
therapeutic use | 28 |
high incidence | 28 |
macaca fascicularis | 28 |
resistant staphylococcus | 28 |
mean age | 28 |
energy transfer | 28 |
compound heterozygous | 28 |
left ventricular | 28 |
several days | 28 |
people worldwide | 28 |
human sting | 28 |
infections caused | 28 |
study provides | 28 |
resistant starch | 28 |
combination therapy | 28 |
seminiferous epithelium | 28 |
different tissues | 28 |
protein complex | 28 |
resistance gene | 28 |
transmission among | 28 |
antioxidant activity | 28 |
translational modifications | 28 |
clinical microbiology | 28 |
large amount | 28 |
scid mice | 28 |
primary spermatocytes | 28 |
cell fusion | 28 |
hyaluronic acid | 28 |
heavy metals | 28 |
previous study | 28 |
ns protein | 28 |
ai technocracy | 28 |
neisseria meningitidis | 28 |
host defenses | 28 |
normal pregnancy | 28 |
developmental stages | 28 |
human peripheral | 28 |
click chemistry | 28 |
clinical course | 28 |
viral proteomes | 28 |
immune defenses | 28 |
tumor tissue | 28 |
respiratory system | 28 |
coronary artery | 28 |
molecular techniques | 28 |
among patients | 27 |
experimental method | 27 |
term effects | 27 |
potential source | 27 |
nude mice | 27 |
specific human | 27 |
leukemia virus | 27 |
pcr products | 27 |
commonly associated | 27 |
national cancer | 27 |
pathogenic microorganisms | 27 |
human neutrophils | 27 |
methods used | 27 |
growth rate | 27 |
villous explants | 27 |
recent work | 27 |
tissue factor | 27 |
international community | 27 |
took place | 27 |
liver damage | 27 |
highly effective | 27 |
quantified using | 27 |
develop new | 27 |
xy gonadal | 27 |
display technology | 27 |
killer cell | 27 |
abdominal pain | 27 |
circulating evs | 27 |
protein targets | 27 |
renal syndrome | 27 |
genetic differences | 27 |
one case | 27 |
eastern equine | 27 |
sequencing data | 27 |
vitro assays | 27 |
testicular torsion | 27 |
many diseases | 27 |
challenge studies | 27 |
cell interactions | 27 |
affected individuals | 27 |
high density | 27 |
blood group | 27 |
expression data | 27 |
virus taxonomy | 27 |
lavage fluid | 27 |
antibody phage | 27 |
jakob disease | 27 |
hepg cells | 27 |
corona virus | 27 |
mitochondrial dysfunction | 27 |
insulin secretion | 27 |
regulatory proteins | 27 |
functional assays | 27 |
cryptococcus neoformans | 27 |
human history | 27 |
typhoid fever | 27 |
blood glucose | 27 |
may even | 27 |
also called | 27 |
well documented | 27 |
cancer stem | 27 |
potential biomarkers | 27 |
intestinal stem | 27 |
within hours | 27 |
erotic cognition | 27 |
tumour cell | 27 |
virus causes | 27 |
genetic risk | 27 |
therapeutic options | 27 |
mg dl | 27 |
cell transplant | 27 |
cynomolgus monkey | 27 |
enzymatic synthesis | 27 |
study also | 27 |
liquid interface | 27 |
promoter region | 27 |
pan troglodytes | 27 |
reduced expression | 27 |
sustained human | 27 |
present work | 27 |
salmonella infection | 27 |
biological function | 27 |
skin lesions | 27 |
tohuman transmission | 27 |
female mice | 27 |
nhp models | 27 |
antibody titers | 27 |
global distribution | 27 |
ion trap | 27 |
cell lung | 27 |
much greater | 27 |
past decade | 27 |
disease pathogenesis | 27 |
sierra leone | 27 |
animal disease | 27 |
related activities | 27 |
strong evidence | 27 |
rapid detection | 27 |
throughput sequencing | 27 |
high molecular | 27 |
older children | 27 |
one must | 27 |
high expression | 27 |
therapeutic strategy | 27 |
fluorescence microscopy | 27 |
follicular fluid | 27 |
protective role | 27 |
fi ed | 27 |
antibody libraries | 27 |
surface glycoproteins | 27 |
cells per | 27 |
nk cell | 27 |
zinc finger | 26 |
vitro models | 26 |
schistosoma mansoni | 26 |
hand hygiene | 26 |
mouse lung | 26 |
regression analysis | 26 |
molecular mass | 26 |
health policy | 26 |
identify novel | 26 |
high number | 26 |
many aspects | 26 |
genes identified | 26 |
igg antibodies | 26 |
significantly greater | 26 |
acquired immunodeficiency | 26 |
ionic liquid | 26 |
barley grass | 26 |
gene regulatory | 26 |
elderly patients | 26 |
showed similar | 26 |
cho cells | 26 |
study found | 26 |
industrialized countries | 26 |
testicular function | 26 |
derived peptides | 26 |
fetal sheep | 26 |
human case | 26 |
available online | 26 |
ubiquitously expressed | 26 |
early onset | 26 |